United Therapeutics UTHR Return on equity

Return on equity at other companies

Tenet HealthcareTHC

75.5%+9.1pp

Johnson & JohnsonJNJ

25.7%-4.5pp

Merck & Co.MRK

19%-20.3pp

InsmedINSM

-294.5%—

Ethos Technologies, Inc. LIFE

-105.3%+50.6pp

LQD

Liquidia CorporationLQDA

-181%+57.4pp

FAQ

What is United Therapeutics's return on equity?

United Therapeutics (UTHR) reported return on equity of 20.3% in Q1 2026.

How has United Therapeutics's return on equity changed year-over-year?

United Therapeutics's return on equity increased by 1.6% year-over-year, from 19.9% to 20.3%.

What is the long-term trend for United Therapeutics's return on equity?

Over 5 years (2020 to 2025), United Therapeutics's return on equity has grown at a 3.4% compound annual growth rate (CAGR), from 16.7% to 19.7%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.